Parametric Portfolio Associates’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Parametric Portfolio Associates's NEO Position: Q1 2022 in Review
Parametric Portfolio Associates increased its NeoGenomics (NEO) stake by 68% in Q1 2022, buying an estimated $3.53M and bringing the position to 414,559 shares worth $5.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1851.
Parametric Portfolio Associates first reported a position in NEO in Q4 2015 and has held it in 26 quarters since. The position peaked at $13.7M in Q4 2020. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.
- Parametric Portfolio Associates held 414,559 shares of NeoGenomics worth $5.04M as of Q1 2022.
- Parametric Portfolio Associates bought 167,942 NeoGenomics shares in Q1 2022, an estimated $3.53M.
- NeoGenomics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1851 holding.
- Parametric Portfolio Associates first reported a position in NeoGenomics in Q4 2015 and has held it in 26 quarters since.
- Parametric Portfolio Associates's NeoGenomics position peaked at $13.7M in Q4 2020.
- 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.